MENEGAZZO, LISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.576
EU - Europa 280
AS - Asia 180
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 3.042
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.573
CN - Cina 151
SE - Svezia 66
IT - Italia 52
DE - Germania 48
FI - Finlandia 46
GB - Regno Unito 39
VN - Vietnam 18
UA - Ucraina 13
IN - India 9
GR - Grecia 6
EU - Europa 5
AT - Austria 3
CA - Canada 3
IE - Irlanda 2
JP - Giappone 2
PT - Portogallo 2
FR - Francia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 3.042
Salva come PNG Salva come JPEG
Città #
Fairfield 444
Ann Arbor 296
Woodbridge 281
Chandler 239
Houston 239
Seattle 172
Ashburn 167
Wilmington 146
Cambridge 142
Jacksonville 62
Princeton 39
Beijing 31
San Diego 29
Roxbury 25
Boardman 23
Medford 23
Padova 23
Nanjing 21
Des Moines 20
Helsinki 19
Dong Ket 18
Guangzhou 18
Dearborn 12
New York 9
Shanghai 9
Jinan 8
Nanchang 8
Redwood City 7
Cagliari 6
Kunming 6
London 6
Shenyang 6
Changsha 5
Hebei 5
Hefei 5
Munich 4
Tianjin 4
Auburn Hills 3
Chicago 3
Jiaxing 3
Taizhou 3
Tappahannock 3
Zhengzhou 3
Borås 2
Dublin 2
Fuzhou 2
Hangzhou 2
Indiana 2
Kharkiv 2
Los Angeles 2
Milan 2
Miranda do Corvo 2
Ningbo 2
North York 2
Norwalk 2
Vienna 2
Canelli 1
Castel Maggiore 1
Chaoyang 1
Chiswick 1
Edinburgh 1
Falls Church 1
Ferentino 1
Frankfurt am Main 1
Hounslow 1
Huzhou 1
Kilburn 1
Lanzhou 1
Lappeenranta 1
Mahbubnagar 1
Monmouth Junction 1
Montréal 1
New Delhi 1
Ogden 1
Pinehaven 1
Redmond 1
Rockville 1
San Mateo 1
Simi Valley 1
Timisoara 1
Torino 1
Vicenza 1
Wandsworth 1
Ürümqi 1
Totale 2.649
Salva come PNG Salva come JPEG
Nome #
NETosis delays diabetic wound healing in mice and humans 168
Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing Oncostatin M. 167
Diabetes-associated myelopoiesis drives stem cell mobilopathy through an OSM-p66Shc signaling pathway 155
NETosis is induced by high glucose and associated with type 2 diabetes. 141
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans 134
A perspective on NETosis in diabetes and cardiometabolic disorders 124
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo 120
Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression 120
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1 119
Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. 117
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients. 109
Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes 109
Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice 108
Diabetes Limits Stem Cell Mobilization Following G-CSF but not Plerixafor. 101
The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing 100
Pharmacologic targeting of endothelial progenitor cells. 99
Endothelial progenitor cells in diabetes mellitus. 96
The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients. 88
Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression 88
Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy. 87
Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells 85
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. 82
Endothelial dysfunction in diabetes: the role of reparatory mechanisms. 78
Diabetes modifies the relationships among carotid plaque calcification, composition and inflammation 78
The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients. 75
Circulating smooth muscle progenitors and atherosclerosis. 71
Effects of Age, Diabetes, and Vascular Disease on Growth Differentiation Factor 11: First-in-Human Study 66
Diabetes mellitus impairs circulating proangiogenic granulocytes 54
Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. 50
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes 49
Identification, characterization and pathophysiological role of circulating myeloid calcifying cells in diabetic vasculopathy 41
Totale 3.079
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.080
article - articoli 9.830
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.910
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019233 0 0 0 0 0 0 0 0 0 46 90 97
2019/2020729 69 36 8 61 75 71 102 79 78 57 57 36
2020/2021603 29 52 29 32 27 38 13 46 75 151 68 43
2021/2022482 12 48 84 31 33 17 24 61 21 4 52 95
2022/2023417 66 59 6 93 44 54 1 16 43 7 20 8
2023/2024130 13 22 21 16 4 14 3 14 1 22 0 0
Totale 3.079